The focus of hepatocellular carcinoma (HCC) research for many years has been on
noninvasive diagnosis. Standardized systematic algorithms composed of combinations of …

The heterogeneity of hepatocellular carcinoma (HCC) commonly leads to therapeutic failure
of HCC. Cytokeratin 19 (CK19) is well acknowledged as a biliary/progenitor cell marker and …

Purpose To (a) evaluate the postsurgical prognostic implication of the Liver Imaging
Reporting and Data System (LI-RADS) categories of primary liver cancers and (b) determine …

Background The recently described “macrotrabecular-massive”(MTM) histologic subtype of
hepatocellular carcinoma (HCC)(MTM-HCC) represents an aggressive form of HCC and is …

Background Hepatocellular carcinomas (HCCs) are heterogeneous neoplasms, and the
prognosis varies based on the subtype. Two broad molecular classes of HCC have been …

Hepatocellular carcinoma (HCC) is a malignancy with variable biologic aggressiveness
based on the tumor grade, presence or absence of vascular invasion, and pathologic and …

Background This study was performed to prospectively develop and validate a radiomics
nomogram for predicting postoperative early recurrence (≤ 1 year) of hepatocellular …

Background Imaging markers of hepatocellular carcinoma (HCC) on the basis of molecular
classification are important for predicting malignancy grade and prognosis. P53-mutated …

Background Hepatocellular carcinomas (HCCs) can be divided into proliferative and
nonproliferative types, which may have implications for outcomes after conventional …

Objectives The accurate prediction of post-hepatectomy early recurrence in patients with
hepatocellular carcinoma (HCC) is crucial for decision-making regarding postoperative …